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Background: The PVL-positive ST772-MRSA-V is an emerging community-associated (CA-) MRSA clone that has
been named Bengal Bay Clone since most patients have epidemiological connections to the Indian subcontinent. It
is found increasingly common in other areas of the world.
Methods: One isolate of ST772-MRSA-V was sequenced using the Illumina Genome Analyzer System. After initial
assembling the multiple sequence contigs were analysed using different in-house annotation scripts. Results were
compared to microarray hybridisation results of clinical isolates of ST772-MRSA-V, of related strains and to another
ST772-MRSA-V genome sequence.
Results: According to MLST e-burst analysis, ST772-MRSA-V belongs to Clonal Complex (CC)1, differing from ST1
only in one MLST allele (pta-22). However, there are several additional differences including agr alleles (group II
rather than III), capsule type (5 rather than 8), the presence of the egc enterotoxin gene cluster and of the
enterotoxin homologue ORF CM14 as well as the absence of the enterotoxin H gene seh. Enterotoxin genes sec
and sel are present. ST772-MRSA-V harbours the genes encoding enterotoxin A (sea) and PVL (lukS/F-PV). Both are
located on the same prophage.
Conclusions: ST772-MRSA-V may have emerged from the same lineage as globally spread CC1 and CC5 strains. It
has acquired a variety of virulence factors, and for a CA-MRSA strain it has an unusually high number of genes
associated with antibiotic resistance.Background
In recent years the epidemiology of methicillin-resistant
Staphylococcus aureus (MRSA) has changed with the
emergence of community associated MRSA (CA-MRSA)
strains. Unlike the original healthcare associated MRSA
strains, CA-MRSA strains are no longer restricted to the
hospital setting and can persist in and be transmitted by
healthy individuals in the community. Some of these
strains exhibit an enhanced virulence due to the car-
riage of a number of virulence genes, including the
Panton Valentine leukocidin (PVL) lukF-PV and lukS-
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reproduction in any medium, provided the ortoxin [1] associated with chronic/recurrent skin and soft
tissue infections and with necrotising pneumonia and
fasciitis [2].
ST772-MRSA-V, colloquially known as the Bengal Bay
Clone [3], is a multiresistant PVL-positive CA-MRSA
initially isolated in India in 2004/2005 [4]. Transmission
of Bengal Bay MRSA has subsequently occurred in
several countries including England [3], Ireland [5],
Germany (H.J. Linde, Regensburg, Germany, pers. com-
munication; [6]), Norway (H. Aamot, pers. communica-
tion), Italy [7,8], Abu Dhabi [6,9], Saudi Arabia [10],
Hong Kong [6], Malaysia [11], Australia [12] and New
Zealand [13]. Many patients had a travel history or
family background suggesting an infection in India,
Pakistan or Bangladesh ([3,5,12]; H.J. Linde, Regensburg,
Germany, pers. communication; author’s unpublished
observations), where this strain appears to be increas-
ingly common [14,15].al Ltd. This is an open access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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One isolate of ST772-MRSA-V (07–17048) was selected
for next generation genome sequencing. It was isolated
from an Indian healthcare worker in Western Australia
as part of standard patient care in 2007 and submitted
to the Australian Collaborating Centre for Enterococcus
and Staphylococcus Species for typing. Thirteen related
isolates that were previously submitted for typing pur-
poses to the participating institutions were selected.
Their microarray hybridisation profiles where compared
to isolate 07–17048 especially with regard to genes asso-
ciated with resistance or virulence (Table 1, Additional
file 1).
Methods
High-throughput de novo sequencing was undertaken
commercially by Geneservice Source BioScience plc
(Nottingham, United Kingdom) using the Illumina Gen-
ome Analyzer System (Illumina Hiseq 2000 platform,
Illumina, Essex, United Kingdom). The average genome
coverage was ca. 105. The reads were assembled to
contigs using the Velvet de novo genome assembler
(vers.1.0.15; Illumina). The project was registered with
the NCBI BioProject database under the provisional ac-
cession number PRJNA207032 and has been deposited
at DDBJ/EMBL/GenBank under the accession number
AZBT00000000.
Microarray procedures have been previously described
in detail [6].
Analysis
Analysis was performed using automated scripts for full
text comparison and BLAST analysis and an in-house
database of known, annotated and previously identified
S. aureus genomes, genes and gene fragments to the
query sequence. This allows determination of identity,
clonal parentage and (given the constant order of core
genomic genes in S. aureus) position within the genome
of each contig (Additional file 2). In parallel, iterated
BLAST searches were used for analysis of individual
contigs in order to confirm results (http://blast.ncbi.nlm.
nih.gov/Blast.cgi; [20]).
Results and discussion
In terms of microarray hybridisation patterns, the se-
quenced strain represents the typical and most common
variant of the Bengal Bay Clone (Table 1 and Additional
file 1). The isolate 07–17048 was found to belong to the
multilocus sequence type (MLST) ST772 (1-1-1-1-22-1-1),spa type t3387 (RIDOM nomenclature, [21], repeat se-
quence 26-16-21-17-34-33-34) and dru type dt10ao (5a-
4a-0-2d-5b-3a-2 g-3b-4e-3e). According to MLST e-burst
analysis, ST772 is considered to belong to CC 1 as it dif-
fers from ST1 only in one MLST allele (pta-22). However,
because of several differences, as shown below, its inclu-
sion into CC1 needs to be re-assessed.
A total of 340 contigs were obtained after initial as-
sembling. Seventy contigs consisting of 2,741,418 base
pairs have been analysed (Additional file 2). The overall
G/C content was 33%. 1,946 protein coding sequences
have been identified (Additional file 3). 1,234 protein
coding sequences were completely identical to previ-
ously identified genes from other S. aureus strains. A
total number of 416, 239 and 101 protein coding se-
quences were completely identical to alleles from CC1
genome sequences (from MSSA476, GenBank accession
number BX571857 and MW2-USA400, BA000033), CC5
genome sequences (from Mu50, BA000017; ED98, CP001781
and N315, BA000018) and CC8 genome sequences (from
COL, CP000046; Newman, AP009351 and NCTC8325,
CP000253) respectively. Three-hundred eighty-three genes
were identical only to another ST772-MRSA-V sequence
(strain 118, whole genome shotgun project AJGE00000000,
[22]). Based on identities to previously published gene se-
quences, ST772-MRSA-V is most closely related to CC1
and CC5. Genes of CC1 and CC5 backgrounds are scat-
tered across the genome, and no evidence for a distinct
part of the genome being affected by a genomic replace-
ment (as observed in, for instance, ST239; [23]) can be
found. Theoretically, this may be attributed to a high num-
ber of recombination events involving CC1 and CC5
strains, or may indicate a common ancestry for both line-
ages and subsequent accumulation of random mutations
in genes that are essentially orthologs in CC1, CC5 and
ST772. The question whether the presence of different
capsule types and agr groups in otherwise closely related
strains (such as ST1 and ST772) can be attributed to re-
combination or to convergent evolution justifies further
study.
Several fundamental differences in the ST772 and CC1
core genomic markers have already been identified by
microarray DNA [6] and have been confirmed by se-
quencing. These differences include agr alleles (group II
rather than III), the capsule type (5 rather than 8) and
the presence of different allelic variants of hlb, ssl01/
set6, bbp, clfB, fnbB, sdrC, sdrD, vwb and hsdS. The egc
enterotoxin gene cluster, Q7A4X2 (a hypothetical pro-
tein localised close to egc), the metallothiol transferase
gene fosB and the enterotoxin homologue ORF CM14
are present in ST772 but absent from other CC1 strains.
The genes seh (encoding enterotoxin H), lukD/E (a leuko-
cidin homologue), splA/B/F (serine proteases), ssl11/set2,
ssl06/set21 (superantigen-like proteins), and Q2FXC0
Table 1 Overview on typing and microarray hybridisation data for CC1 refe nce strains (nr. 1 and 2), CC5 reference strains (nr. 3 and 4), the strain described
herein (nr. 5), other Bengal Bay isolates (nr. 6 to 14) and other, related stra s (nr. 15 to 18)






ccrA/B-1 ccrA/B-2 ccrAA/C kdp SCC
locus
blaZ/R/I erm(C) msr(A) +mph(C) aacA-aphD aadD
1 MW2 US [16] t128 ST1 III 8 + + - + - - + - - - -
2 Sanger 476 UK [17] t607 ST1 III 8 - - + - - - + - - - -
3 N315 Japan [18] t002 ST5 II 5 + + - + - + + - - - +
4 Mu50 Japan [18] t002 ST5 II 5 + + - + - + - - - + +
5 07-17048 WA/India [6,12] t3387 ST772 II 5 + - - - + - + - + + -
6 09 V32405 Saxony [6] n.a. n.a. II 5 + - - - + - + + + + -
7 10 V3510 Saxony/India [6] n.a. n.a. II 5 + - - - + - + - + + -
8 11ANR12420 Saxony - n.a. n.a. II 5 + - - - + - + - + + -
9 12ANR75832 Saxony - n.a. n.a. II 5 + - - - + - + - + + -
10 11-18844 WA - t657 n.a. II 5 + - - - + - + - + - -
11 11-18907 WA - t657 n.a. II 5 + - - - + - + - + + -
12 11-19350 WA - t4599 n.a. II 5 + - - - + - + - - + -
13 11-19415 WA - t657 n.a. II 5 + - - - + - + - + + -
14 11-19454 WA - t1075 n.a. II 5 + - - - + - + + + + -
15 03-16918
(WA-10)
WA [6,19] t5073 ST573 II 5 + - - - + - + - - - -
16 11-16548 WA - n.a. ST772 II 5 + - - - + - + - + + -
17 05 V02622 Saxony - n.a. n.a. II 5 - - - - - - + - - - -























Table 1 Overview on typing and microarray hybridisation data for CC1 reference strains (nr. 1 and 2), CC5 reference strains (nr. 3 and 4), the strain described
herein (nr. 5), other Bengal Bay isolates (nr. 6 to 14) and other, related strains (nr. 15 to 18) (Continued)
Nr. aphA3 + sat fusC
(Q6GD50)






lukF/S-PV lukD/E sak chp scn splA + splB
1 - - - - - + - + - - + + - + + + - + +
2 - + - - - + - - - - + + - - + + - + +
3 - - - - + - + + - + - - - - + + + + +
4 - - - + + + - + - + - - - - + + - + +
5 + - - - - + - + - + - - + + - - - + -
6 + - - - - + - + - + - - + + - - - + -
7 + - - - - + - + - + - - + + - - - + -
8 + - - - - + - + - + - - + + - - - + -
9 + - - - - + - + - + - - + + - - - + -
10 + - - - - + - + - + - - + + - - - + -
11 + - - - - + - + - + - - + + - - - + -
12 - - - - - + - + - + - - + + - - - + -
13 + - - - - + - + - + - - + + - - - + -
14 + - - - - + - + - + - - + + - - - + -
15 - - - - - - - + - + - - + - - - - + -
16 + - - - - - - + - + - - + - - - (+) + -
17 - - - - - - - + - + - - + - - - - + -
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eron) are absent in ST772, but present in other CC1
strains. In lieu of seh, the enterotoxin homologue ORF
CM14 was identified in a similar position, i.e., closely
downstream of the integration site of the SCCmec ele-
ment. ORF CM14, absent in the related and possibly par-
ental lineages CC1 and CC5 can be found in a number of
different lineages including CC12, ST93, CC121, CC395
and CC705. This may indicate a small scale genomic re-
placement in a region close/downstream to oriC. Alterna-
tively, ORF CM14 may have been replaced by seh in
ancestors of CC1 or entirely deleted in CC5, but retained
only in ST772.Table 2 Genes associated with the PVL prophage in isolate 07
Designation Explanation Position
contig
tx_lukF-PV Rho-independent terminator of lukF-PV 89974…9
lukF-PV Panton-Valentine leukocidin F 90081…9
lukS-PV Panton-Valentine leukocidin S 91060…9
O80065 Putative protein directly upstream
of lukS-PV - leader-peptide of lukPV
92106…9
tx_amidase1-phiSLT Rho-independent terminator of
bacteriophage amidase
92327…9
amidase1-phi12 Bacteriophage amidase 92388…9
holin1-phiL54a Bacteriophage holin 93853…9
sprFG Small pathogenicity island RNA F and G 94155…9
rli28 Listeria sRNA rli28 homolog, locus 2 94395…9
txpA-phage Toxin involved in plasmid maintenance 94400…9
sea Enterotoxin A 94652…9
minor-phiNM3 Bacteriophage minor structural protein 96751…1
Q8SDK3-phiNM3 Putative bacteriophagal protein 100552…
measure1-phiNM3 Bacteriophage tail length tape
measure protein
102033…
tailL-CC5 Bacteriophage major tail protein 107488…
A0EWZ3 Bacteriophage major capsid protein 109862…
Q6GF91 Putative protease 111031…
portal1-phiNM3 Bacteriophage portal protein type 1 111752…
terminase-phiNM3 Bacteriophagal terminase 112955…
rinB-phiPVL Bacteriophage transcript activator B 116263…
dut-phi Phage dUTP pyrophosphatase 117277…
sri Staphylococcal replication inhibitor 120465…
istB Replicative DNA helicase 120617…
Q4ZAK4 Putative bacteriophagal protein 121406…
ssb3-phage Putative DNA binding protein 123346…
DUF2483-phi80a Putative bacteriophagal protein 124707…
ant-phiPV83 Bacteriophage antirepressor 127131…
repressor-var3 Bacteriophage repressor 128338…
int1-phiPVL01 Bacteriophage integrase 131132…Isolate 07–17048 harbours the enterotoxin A and PVL
encoding sea and lukF/S-PV genes. Both genes are lo-
cated on the same contig, and together with several
other phage-associated genes, appear to be on a novel
prophage. The phage is integrated into a gene of the pu-
tative protein A5IT17 which contains an attachment site
of the PVL-carrying phage previously identified in other
strains (un-truncated in the CC1 strain MSSA476,
BX571857.1: SAS1429; truncated in the CC1 strain
MW2-USA400, BA000033.2: MW1377/1443). All phage-
associated genes identified are shown in Table 2.
Genes sea and sprFG are normally associated with hae-
molysin beta converting phages rather than with PVL-17048
in Length Best match
0030 56 MW2-USA400, BA000033.2 [1529274:1529329:r]RC
1059 978 MW2-USA400, BA000033.2 [1529381:1530358:r]RC
1999 939 CIGC128, AHVY01000005.1 [221466:222404:r]RC
2239 133 CIGC128, AHVY01000005.1 [222512:222644:r]RC
2383 56 TCH1516, CP000730.1 [1562363:1562418:r]RC
3843 1455 MW2-USA400, BA000033.2 [1531688:1533142:r]RC
4156 303 MSSA476, BX571857.1 [1023464:1023766]RC
4266 211 ED98, CP001781.1 [892742:892952:r]
4574 179 MW2-USA400, BA000033.2 [2051199:2051377:r]RC
4535 1662 MW2-USA400 BA000033.2[2051171:2051305:r]RC
5426 774 ST772 strain 118, AJGE01000058.1 [57550:58323]RC
00537 3786 TCH70-ST1, ACHH02000016.1 [79909:83694]RC
102037 1485 ST772 strain 118, AJGE01000058.1 [50939:52423]RC
106578 4545 04-02981, CP001844.2 [2051791:2056320:r]RC
108133 645 N315, BA000018.3 [2024201:2024845:r]RC
111008 1146 Mu50-VRSA, BA000017.4 [2103511:2104656:r]RC
111769 738 A9299, ACKH01000012.1 [7311:8048]RC
112940 1188 Mu50-VRSA, BA000017.4 [2105401:2106588:r]RC
114617 1662 Mu50-VRSA, BA000017.4 [2106604:2108265:r]RC
116413 150 TCH1516, CP000730.1 [2111630:2111779:r]RC
117820 543 MRSA252, BX571856.1 [2152883:2153425:r]RC
120624 159 AP009351.1 [1110173:1110331]RC
121397 780 phage, FJ713816.1 [12631:13404]RC and 04–02981,
CP001844.2 [886487:887266]RC
122177 771 04-02981, CP001844.2 [885707:886477]RC
123898 552 NCTC8325, CP000253.1 [2065949:2066500:r]RC
124929 222 H19, ACSS01000056.1 [6024:6245:r]RC
127929 798 phage, AY508486.1 [26092:26889]RC
129067 729 phage, AP001553.1 [2342:3070:r]
132338 1206 ST772 strain 118, AJGE01000058.1 [20637:21842:r]
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rupted, but there is no complete phage integrated into
that gene. Only genes encoding the staphylococcal com-
plement inhibitor scn, the putative membrane protein
Q6GFB6 (usually located next to scn on hlb-converting
phages, e.g., in genomes of USA300 and USA400, N315,
Mu50, NCTC8325, MRSA252, MSSA476) and sprD (cod-
ing for small pathogenicity island RNA D) can be found
within hlb. A possible assembly error affecting both phage
integration sites is highly unlikely. Several other ST772-
MRSA-V genome sequences [22,24] also show this associ-
ation of lukF/S-PV with sea. Besides, rare naturally occurring
variants of ST772-MRSA-V and the related (single locus
variant) ST573-MRSA-V (WA MRSA-10, [19]) lack lukS/
F-PV and sea while still harbouring scn. Similar constella-
tions can also be observed in ST573/772 MSSA (Table 1).
Thus it is more likely that a part of the hlb-converting
phage was translocated into a PVL phage that is integrated
into a different position of the staphylococcal genome.
Other genes that are associated with mobile genetic el-
ements include enterotoxin genes sec and sel. They are
localised in similar position and context as in MW2,
where they are also accompanied by phage derived genes
and by the gene ear encoding the enterotoxin-linked
ampicillin resistance protein. For resistance genes blaZ/I/
R, msr(A), mph(C), aacA-aphD, aphA3, sat and aadE it
was not possible to unambiguously determine with the
given set of contigs whether they were situated on the
chromosome or on plasmids. The macrolide/clindamycin
resistance gene erm(C), and msr(A), mph(C), aacA-aphD,
aphA3 and sat genes have been shown by microarray hy-
bridisation to occur variably in ST772-MRSA-V (Table 1).
The isolate 07–17048 harbours a SCCmec V element. Its
terminal sequence towards orfX was also present in an-
other ST772-MRSA-V sequence (strain 118, [22]) and
appears to be unique to ST772-MRSA-V. The SCCmec V
element consists of a tnpIS431-04, mvaS-SCC (a truncated
3-hydroxy-3-methylglutaryl CoA synthase), a putative pro-
tein Q5HJW6, dru (SCC-associated direct repeat units),
ugpQ (glycerophosphoryl diester phosphodiesterase),
ydeM (a putative dehydratase), a bidirectional rho-inde-
pendent terminator of mecA followed by mecA in an al-
lelic variant identical to GQ902038 and AM990992 [25], a
series of genes coding for putative proteins (Q4LAG7,
Q3T2N0, Q4LAG4, Q4LAG3, Q3T2M7), a recombinase
homologue “ccrAA” [26], a SCCmec type V recombinase
ccrC, further genes encoding putative proteins (Q4LAF9,
Q7A206, Q7A207, Q9KX75, A9UFT0), a bidirectional rho-
independent terminator of hsdR and three genes (hsdR,
hsdS, hsdM2) of a type I restriction-modification system.
Conclusion
In conclusion, ST772-MRSA-V may have emerged from
the same root or lineage as the global CC1 and CC5strains. It has acquired a variety of virulence factors,
and, compared to other CA-MRSA strains, it has an un-
usually high number of genes associated with antibiotic
resistance. Whether it evolved in a hospital setting or ac-
quired these genes in community cannot be decided
based on a single sequence. Therefore, more epidemio-
logical data and possibly the sequencing of a number of
additional isolates are warranted in order to understand
the evolution and spread of this conspicuous strain.
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